Medical students at Duke University finally have their own home after being spread out over the medical campus for 73 years. Filled with natural light from the glass walls and study nooks for doing work, this building is a gorgeous feat of architecture. It has been named the Mary Duke Biddle Trent Semans Center for Health Education, and it’s located right in the middle of the medical campus. The center provides a space for medical students who used to have to study in the basement of Duke Medicine’s Purple Zone, the Davison Building and every so often, spaces rented for large gatherings.
Tags: 2014, 2013, Medical Research, Duke University, North Carolina, Mary Duke Biddle Trent Semans Center, Southern, BioResearch Product Faire Event, Durham, NIH, NC, science researcher, science research trade show, Duke, NSF, new Building, lab supplier
Science researchers at the University of North Carolina at Chapel Hill recently conducted a study that shows that boys in the United States are entering into puberty earlier than in the past, sometimes as young as at the age of nine, according to a UNC Chapel Hill news article. The research was published online in the journal Pediatrics and presented on October 20th at an American Academy of Pediatrics (AAP) conference and exhibition in New Orleans.
Duke University research scientist Robert Lefkowitz, 69, says he was fast asleep when the Nobel committee called to tell him he had won the prestigious prize, but he said he didn’t hear the phone ring because he was wearing ear plugs. His wife picked up the phone.
Science researchers at the University of Texas at Austin have received a $3.3 million, five-year grant from the National Institute on Alcohol Abuse and Alcoholism to work on a medication to treat alcoholism and drug addiction, according to a UT Austin news article. The donating institute is a part of the National Institutes of Health.
Science researchers at Washington University School of Medicine in St. Louis are offering to sequence the DNA of 99 patients with rare genetic diseases in order to find the genetic alterations that made them ill. The new effort, known as the Rare99X Clinical Exome Challenge, will allow patients’ DNA to be decoded at the university’s Genomics and Pathology Services (GPS) at no cost to the patients or advocacy groups who represent them.